Scheffer Tseng, MD, PhD
Chief Technology Officer, TissueTech, Inc.
It is our pleasure to invite you to join world renowned, Scheffer Tseng, MD, PhD, for a special educational discussion and in-depth look at the use of placental tissue in modern medicine and how it is advancing the standard of care.
Today, Umbilical Cord and Amniotic Membrane Transplantation as an adjunctive technology is being rapidly adapted in multiple disciplines of medicine. Through his 30 years of NIH-funded research demonstrating the regenerative healing properties and efficacy of placental tissue, Dr. Tseng identified that the preservation of the tissue’s biological and structural integrity is key to providing optimal healing in a variety of clinical indications. The clinical potential of placental tissue has been reported in more than 300 peer-reviewed publications and is at the core of the clinical advancement in regenerative therapy technology that Dr. Tseng has developed and will discuss.